A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the treatment of Prader-Willi Syndrome, diabetes, obesity and other metabolic disorders such as non-alcoholic steatohepatitis (NASH). 

Pharmaceutical

Inversago Pharma

Inversago Pharma's headquarters in Montreal, Canada

Karine Lalonde

Michael D. Harvey

Jianmin Duan

Jean-Daniel Bélanger

Micheline Beauvais

Michèle Desjardins

John Babetas

Sabina Bangash

Christine McCarthy

Arun J. Sanyal

Rohit N. Kulkarni

George Kunos

David Cherney

John J.P. Kastelein

Jean-Pierre Després

Description

People (1)

Sabina Bangash

Jobs